Mindfulness-Based Relapse Prevention for Peer Workers
Official title: Adapting and Pilot Testing Mindfulness-Based Relapse Prevention for Substance Use Peer Workers
Run by University of Texas at Austin · NCT07741825 · Data updated 2026-11-12
We’re testing whether Mindfulness-Based Relapse Prevention can help substance-use peer workers cut down on use and burnout compared with usual referrals to a 12-step program.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 18 Years to 100 Years |
| Sex | All |
| Enrollment | 80 (estimated) |
| Sponsor | University of Texas at Austin Academic / other |
| Locations | 1 site (Austin, Texas) |
| Status | Recruiting |
| Started | August 2026 |
| Main results expected | July 2030 |
| Study ends | July 2030 |
| Registry record updated | August 7, 2026 |
| Trial ID | NCT07741825 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Adults employed in substance-use peer-support roles, fluent in English, with elevated craving indicating relapse risk.
✕Probably not a fit
Individuals with cognitive impairment, active suicidality or psychosis, or those not in a peer-support role may not benefit in this trial.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This pilot hybrid type 1 trial adapts Mindfulness-Based Relapse Prevention (MBRP) for substance-use peer workers. Participants will complete eight weekly 2-hour virtual sessions of MBRP or be referred to standard 12-step care, with outcomes focusing on substance use, relapse risk, and burnout. The study aims to identify relapse factors, tailor content for peers, and assess preliminary effectiveness and implementation aspects of the adapted intervention. The trial is conducted at the University of Texas at Austin with an Addiction Research Institute site, enrolling adults who are employed in peer-support roles and fluent in English. Eligible participants will have a craving score indicating relapse risk and must not have cognitive impairments or active psychosis or suicidality.
Why it matters
Potential benefit: If successful, peers may experience reduced substance use and burnout and improved coping skills.
How similar studies have gone: Prior research suggests mindfulness-based approaches can reduce relapse risk in related populations, but adapting MBPRP for peer workers is relatively novel and exploratory.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: 1. Are \> 18 years old 2. Fluent in English 3. Be currently employed in a substance use peer support role 4. At-risk for SUD relapse as measured by a craving score of \>15 on the adapted Penn Alcohol Craving Scale Exclusion Criteria: 1. Have a cognitive impairment that jeopardizes informed consent 2. Actively suicidal or psychotic
Where it's running
-
Addiction Research Institute
Austin, Texas, United States Recruiting
Study contacts
- Study coordinator: Katie A McCormick, PhD, MSW
- Email: katie.mccormick@austin.utexas.edu
- Phone: (512) 471-5457
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Using voice patterns to detect burnout in healthcare workers
This study tests whether speech and voice signals can reveal burnout and stress in clinicians and whether a stress-management device changes those voice markers.
-
Floatation-REST for frontline workers with post-traumatic stress symptoms
This early pilot tests whether two 60-minute Floatation-REST sessions can be safely tried by frontline healthcare workers and first responders who have post-traumatic stress symptoms, compared to watching a documentary.
-
Student Midwife Support Circle to reduce burnout and strengthen resilience and professional belonging
This project will try a Student Midwife Support Circle with midwifery students to see if it lowers burnout and increases resilience and a sense of professional belonging.
-
Strengthening compassion in hospital care at Herlev and Gentofte
This project will test whether translated questionnaires can reliably measure compassion for Danish patients and healthcare staff at Herlev and Gentofte Hospital.
-
Bugitinib with venetoclax and cytarabine for relapsed or refractory acute myeloid leukemia
This trial tests whether the three-drug combination of bugitinib, venetoclax, and cytarabine can clear minimal residual disease in adults with relapsed or refractory AML.
-
Professional Readiness Through Emotional Preparedness (PREP) for Nurse Residents
The PREP program tests a 5-month educational series to see if it improves emotional well-being and work readiness for nurse residents.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.